Journal articles on the topic 'H3.3 K27M oncohistone'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'H3.3 K27M oncohistone.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Liu, Ilon, Jiang Li, Daeun Jeong, Olivia A. Hack, McKenzie Shaw, Bernhard Englinger, Byron Avihai, et al. "EPCO-06. AGE- AND REGION-SPECIFIC MULTI-OMIC CHARACTERIZATION OF H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 23, Supplement_6 (November 2, 2021): vi2. http://dx.doi.org/10.1093/neuonc/noab196.005.
Liu, I., L. Jiang, E. Samuelsson, S. Marco Salas, O. Hack, D. Jeong, M. Shaw, et al. "JS04.6.A The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location." Neuro-Oncology 24, Supplement_2 (September 1, 2022): ii7. http://dx.doi.org/10.1093/neuonc/noac174.021.
Liu, Ilon, Li Jiang, Erik Samuelsson, Sergio Marco Salas, Alexander Beck, Olivia Hack, Daeun Jeong, et al. "DIPG-08. THE LANDSCAPE OF TUMOR CELL STATES AND SPATIAL ORGANIZATION IN H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA ACROSS AGE AND LOCATION." Neuro-Oncology 25, Supplement_1 (June 1, 2023): i14. http://dx.doi.org/10.1093/neuonc/noad073.055.
Hübner, Jens-Martin, Torsten Müller, Dimitris N. Papageorgiou, Monika Mauermann, Jeroen Krijgsveld, Robert B. Russell, David W. Ellison, Stefan M. Pfister, Kristian W. Pajtler, and Marcel Kool. "EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma." Neuro-Oncology 21, no. 7 (April 29, 2019): 878–89. http://dx.doi.org/10.1093/neuonc/noz058.
Liapodimitri, Athanasia, Kayleigh Lunsford, Ashley R. Tetens, Jordyn Craig-Schwartz, Farhad Vesuna, Venu Raman, and Michael A. Koldobskiy. "DIPG-64. UNRAVELING H3K27M INTERACTIONS IN DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 26, Supplement_4 (June 18, 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.117.
Andrade, Augusto Faria, Danai Topouza, Michael McNicholas, Eduardo G. Gonzalez Santiago, Antonella De Cola, Arne Gehlhaar, Selin Jessa, et al. "TMIC-04. IMMUNE PROFILING OF PEDIATRIC ONCOHISTONE GLIOMAS REVEALS DIVERSE MYELOID POPULATIONS AND TUMOR-PROMOTING BEHAVIORS." Neuro-Oncology 25, Supplement_5 (November 1, 2023): v278. http://dx.doi.org/10.1093/neuonc/noad179.1070.
Budd, Kaitlin, Chang-Hyuk Kwon, Lawryn H. Kasper, Christopher Roberts, Jordan Roach, Jennifer Ocasio-Adorno, Jon D. Larson, and Suzanne J. Baker. "Abstract IA007: Transforming chromatin: Oncohistone mutations in pediatric high-grade glioma." Cancer Research 82, no. 23_Supplement_2 (December 1, 2022): IA007. http://dx.doi.org/10.1158/1538-7445.cancepi22-ia007.
Kida, Jun-ichiro, Takayuki Tsujioka, Shin-ichiro Suemori, Shuichiro Okamoto, Kanae Sakakibara, Takahiro Yamauchi, Akira Kitanaka, Yumi Tohyama, and Kaoru Tohyama. "Malignant Progression of an MDS-Derived Cell Line Serves As an in Vitro Model for the Leukemic Evolution of MDS." Blood 132, Supplement 1 (November 29, 2018): 5501. http://dx.doi.org/10.1182/blood-2018-99-110583.
Hohm, Annika, Michael Karremann, Gerrit H. Gielen, Torsten Pietsch, Monika Warmuth-Metz, Lindsey A. Vandergrift, Brigitte Bison, et al. "Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma." Clinical Neuroradiology 32, no. 1 (December 17, 2021): 249–58. http://dx.doi.org/10.1007/s00062-021-01120-3.
Zhang, Peng, Tiantian Han, Yi Lu, Weijie Sun, Wanglong Deng, Guanghua Lu, Didi Guo, Xiaomin Li, and Fanfeng Bu. "Molecular characteristics of H3 K27M mutation gliomas in Chinese adults." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e14018-e14018. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e14018.
Shema, Efrat. "Abstract PR006: Single-molecule and single-cell epigenetics: Decoding the epigenome for cancer research and diagnostics." Cancer Research 82, no. 23_Supplement_2 (December 1, 2022): PR006. http://dx.doi.org/10.1158/1538-7445.cancepi22-pr006.
Morita, Shuhei, Masayuki Nitta, Yoshihiro Muragaki, Takashi Komori, Kenta Masui, Takashi Maruyama, Koichi Ichimura, et al. "Brainstem pilocytic astrocytoma with H3 K27M mutation: case report." Journal of Neurosurgery 129, no. 3 (September 2018): 593–97. http://dx.doi.org/10.3171/2017.4.jns162443.
Odia, Yazmin, Ashley Love Sumrall, Timothy Francis Cloughesy, Phioanh Leia Leia Nghiemphu, Matthew David Hall, Doured Daghistani, Minesh P. Mehta, et al. "Single agent activity of ONC201 in non-midline H3 K27M-mutant diffuse gliomas." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e14037-e14037. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e14037.
Odia, Yazmin, Ashley Sumrall, Timothy Cloughesy, Phioanh Nghiemphu, Matthew Hall, Doured Daghistani, Minesh Mehta, et al. "CTNI-27. SINGLE AGENT ACTIVITY OF ONC201 IN NON-MIDLINE H3 K27M-MUTANT DIFFUSE GLIOMAS." Neuro-Oncology 23, Supplement_6 (November 2, 2021): vi65. http://dx.doi.org/10.1093/neuonc/noab196.252.
Gardner, Sharon L., Carl Johannes Koschmann, Rohinton Tarapore, Jeffrey C. Allen, Wafik Tharwat Zaky, Yazmin Odia, Matthew Hall, et al. "ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 3619. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3619.
Kawakibi, Abed Rahman, Rohinton S. Tarapore, Sharon Gardner, Andrew Chi, Sylvia Kurz, Patrick Y. Wen, Isabel Arrillaga-Romany, et al. "HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA." Neuro-Oncology 22, Supplement_3 (December 1, 2020): iii347. http://dx.doi.org/10.1093/neuonc/noaa222.305.
Kawakibi, Abed Rahman, Rohinton Tarapore, Sharon L. Gardner, Sylvia Christine Kurz, Patrick Y. Wen, Isabel Arrillaga-Romany, Tracy Batchelor, et al. "Clinical efficacy of ONC201 in thalamic H3 K27M-mutant glioma." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 3617. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3617.
Hall, Matthew D., Yazmin Odia, Joshua E. Allen, Rohinton Tarapore, Ziad Khatib, Toba N. Niazi, Doured Daghistani, et al. "First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M–mutant pediatric diffuse intrinsic pontine glioma: a case report." Journal of Neurosurgery: Pediatrics 23, no. 6 (June 2019): 719–25. http://dx.doi.org/10.3171/2019.2.peds18480.
Schulte, Jessica, Robin Buerki, Sarah Lapointe, Annette Molinaro, Yalan Zhang, Javier Villanueva-Meyer, Arie Perry, et al. "PATH-30. CLINICAL AND GENETIC CHARACTERISTICS OF HISTONE H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMAS IN ADULTS." Neuro-Oncology 22, Supplement_2 (November 2020): ii170—ii171. http://dx.doi.org/10.1093/neuonc/noaa215.711.
Liu, Ilon, Li Jiang, Erik R. Samuelsson, Sergio Marco Salas, Alexander Beck, Olivia A. Hack, Daeun Jeong, et al. "The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location." Nature Genetics 54, no. 12 (December 2022): 1881–94. http://dx.doi.org/10.1038/s41588-022-01236-3.
Rahman Kawakibi, Abed, Sharon Gardner, Andrew Chi, Sylvia Kurz, Patrick Wen, Isabel Arrillaga-Romany, Tracy Batchelor, et al. "PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA." Neuro-Oncology 21, Supplement_6 (November 2019): vi186. http://dx.doi.org/10.1093/neuonc/noz175.773.
Qiu, Tianming, Apisara Chanchotisatien, Zhiyong Qin, Jinsong Wu, Zunguo Du, Xialing Zhang, Fangyuan Gong, Zhenwei Yao, and Shuguang Chu. "Imaging characteristics of adult H3 K27M-mutant gliomas." Journal of Neurosurgery 133, no. 6 (December 2020): 1662–70. http://dx.doi.org/10.3171/2019.9.jns191920.
Chen, Xueling, Ling Zhong, Jianwen Lin, and Jian Yu. "A rare case of adult diffuse midline glioma with H3 K27M mutant in the prepontine cistern." Journal of International Medical Research 49, no. 1 (January 2021): 030006052098126. http://dx.doi.org/10.1177/0300060520981266.
Arrillaga-Romany, Isabel, Andrew Lassman, Susan McGovern, Sabine Mueller, L. Burt Nabors, Martin van den Bent, Michael Vogelbaum, et al. "RTID-01. ONC108: A RANDOMIZED PHASE 3 STUDY OF ONC201 IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii249. http://dx.doi.org/10.1093/neuonc/noac209.961.
Arrillaga-Romany, I., A. Lassman, S. L. McGovern, S. Mueller, L. B. Nabors, M. van den Bent, M. Vogelbaum, et al. "P11.46.A ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA." Neuro-Oncology 25, Supplement_2 (September 1, 2023): ii84. http://dx.doi.org/10.1093/neuonc/noad137.280.
Arrillaga-Romany, Isabel, Andrew Lassman, Susan McGovern, Sabine Mueller, Louis Burt Nabors, Martin van den Bent, Michael Vogelbaum, et al. "TIPS-08 ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA." Neuro-Oncology Advances 5, Supplement_3 (August 1, 2023): iii35—iii36. http://dx.doi.org/10.1093/noajnl/vdad070.139.
DeMasters, B. K., Samuel Guzman, and David Ormond. "PATH-18. MORE UNUSUAL FEATURES IN H3 K27M-MUTANT GLIOMAS." Neuro-Oncology 25, Supplement_5 (November 1, 2023): v171. http://dx.doi.org/10.1093/neuonc/noad179.0648.
Arrillaga-Romany, Isabel, Andrew Lassman, Susan L. McGovern, Sabine Mueller, Louis B. Nabors, Martin van den Bent, Michael Vogelbaum, et al. "Abstract CT060: ACTION: A randomized phase 3 study of dordaviprone (ONC201) in patients with newly diagnosed H3 K27M-mutant diffuse glioma." Cancer Research 83, no. 8_Supplement (April 14, 2023): CT060. http://dx.doi.org/10.1158/1538-7445.am2023-ct060.
Gardner, Sharon, Rohinton Tarapore, Jeffrey Allen, Wafik Zaky, Yazmin Odia, Matthew Hall, Doured Daghistani, et al. "DIPG-52. PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG." Neuro-Oncology 22, Supplement_3 (December 1, 2020): iii297. http://dx.doi.org/10.1093/neuonc/noaa222.097.
Gardner, Sharon L., Jeffrey C. Allen, Wafik Tharwat Zaky, Yazmin Odia, Doured Daghistani, Ziad Khatib, Carl Johannes Koschmann, et al. "ONC201 in previously-irradiated pediatric H3 K27M-mutant glioma." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 10046. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10046.
Odia, Yazmin, Carl Johannes Koschmann, Rohinton Tarapore, Jeffrey Allen, Wafik Tharwat Zaky, Matthew David Hall, Doured Daghistani, et al. "Window-of-opportunity study of ONC201 in pediatric patients with diffuse intrinsic pontine glioma (DIPG) and thalamic glioma." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): TPS2082. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.tps2082.
Liu, Ilon, Jiang Li, Erik Samuelsson, Sergio Marco Salas, Alexander Beck, Olivia Hack, Daeun Jeong, et al. "EPCO-21. THE SPATIAL ORGANIZATION OF H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii120. http://dx.doi.org/10.1093/neuonc/noac209.456.
Jia, Deze, Yi Lu, Xiaomin Li, Tiantian Han, Wanglong Deng, Fanfeng Bu, and Guanghua Lu. "Comparison of next-generation sequencing and FISH/IHC for molecular classification in glioma." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e14021-e14021. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e14021.
Odia, Yazmin, Carl Koschmann, Rohinton Tarapore, Jeffrey Allen, Matthew Hall, Doured Daghistani, Ziad Khatib, et al. "SYST-07 WINDOW-OF-OPPORTUNITY STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND THALAMIC GLIOMA." Neuro-Oncology Advances 4, Supplement_1 (August 1, 2022): i22. http://dx.doi.org/10.1093/noajnl/vdac078.086.
Arrillaga-Romany, Isabel, Sylvia Kurz, Ashley Sumrall, Nicholas Butowski, Rebecca Harrison, John DeGroot, Andrew Chi, et al. "ACTR-34. SINGLE AGENT ONC201 IN PREVIOUSLY-TREATED, PROGRESSIVE ADULT H3 K27M-MUTANT GLIOMA." Neuro-Oncology 21, Supplement_6 (November 2019): vi20—vi21. http://dx.doi.org/10.1093/neuonc/noz175.077.
Kurz, Sylvia Christine, Rohinton Tarapore, Yazmin Odia, Nicholas A. Butowski, Carl Johannes Koschmann, Dolly Aguilera, Tobey J. MacDonald, et al. "Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 2563. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.2563.
Arrillaga-Romany, Isabel, Sylvia Christine Kurz, Rohinton Tarapore, Ashley Sumrall, Nicholas A. Butowski, Rebecca A. Harrison, John Frederick De Groot, et al. "Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 3615. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3615.
Gessi, Marco, David Capper, Felix Sahm, Kristin Huang, Andreas von Deimling, Stephan Tippelt, Gudrun Fleischhack, et al. "Evidence of H3 K27M mutations in posterior fossa ependymomas." Acta Neuropathologica 132, no. 4 (August 18, 2016): 635–37. http://dx.doi.org/10.1007/s00401-016-1608-3.
Schniederjan, Matthew J., Cahil Potnis, Varshini Vasudevaraja, Catherine D. Moser, Bethany Watson, Matija Snuderl, Tobey MacDonald, and Beverly B. Rogers. "DNA Methylation Profiles Are Stable in H3 K27M-Mutant Diffuse Midline Glioma Neurosphere Cell Lines." Children 11, no. 4 (April 20, 2024): 492. http://dx.doi.org/10.3390/children11040492.
Diaz, Maria, Carlos Eduardo Silva Correia, Andrew Lin, Alexandra Miller, and Elena Pentsova. "PATH-04. LEPTOMENINGEAL DISEASE IN PATIENTS WITH HISTONE-MUTANT GLIOMAS." Neuro-Oncology 23, Supplement_6 (November 2, 2021): vi115. http://dx.doi.org/10.1093/neuonc/noab196.457.
Porter, William, Joshua Sulman, Katie Foot, Ruman Rahman, Richard Grundy, Robert Layfield, and Farhana Haque. "HGG-47. Comparative analysis of the Histone H3 mutant protein interactome landscape in paediatric high-grade gliomas." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i71—i72. http://dx.doi.org/10.1093/neuonc/noac079.262.
Arrillaga-Romany, Isabel, Sylvia Kurz, Rohinton S. Tarapore, Ashley Sumrall, Nicholas Butowski, Rebecca Harrison, John de Groot, et al. "CTNI-37. EFFICACY OF ONC201 IN PATIENTS WITH ONC201 FOR RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA." Neuro-Oncology 22, Supplement_2 (November 2020): ii50—ii51. http://dx.doi.org/10.1093/neuonc/noaa215.204.
Haque, Farhana. "Comparative Analysis of the Histone H3 Mutant Protein Interactome Landscape in Paediatric High-Grade Gliomas." Neuro-Oncology 24, Supplement_4 (October 1, 2022): iv4. http://dx.doi.org/10.1093/neuonc/noac200.016.
Balakrishnan, Samantha, Ivan Carabenciov, Michael Ruff, Joon Uhm, and Sani Kizilbash. "RARE-37. TREATMENT OF H3K27M MUTANT GLIOMAS WITH PANOBINOSTAT." Neuro-Oncology 21, Supplement_6 (November 2019): vi229. http://dx.doi.org/10.1093/neuonc/noz175.960.
Sumrall, Ashley Love, Joanne Xiu, Jennifer M. Eschbacher, Sandeep Mittal, Zoran Gatalica, Manjari K. Pandey, Surasak Phuphanich, Wolfgang Michael Korn, Gregory N. Fuller, and Amy B. Heimberger. "Mutations of H3.3 and H3.1 in a large cohort of glioma tumors." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e13540-e13540. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e13540.
Arrillaga, Isabel, Sylvia Kurz, Ashley Sumrall, Nicholas A. Butowski, Rebecca A. Harrison, John Frederick De Groot, Nicole A. Shonka, et al. "Single agent ONC201 in adult recurrent H3 K27M-mutant glioma." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 3005. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3005.
Azadi, Amir, Ekokobe Fonkem, and Tejas Ranade. "EPID-12. TREATMENT OUTCOMES OF MIDLINE GLIOMAS WITH H3K27 M: OUR BARROW NEUROLOGICAL INSTITUTE EXPERIENCE." Neuro-Oncology 22, Supplement_2 (November 2020): ii81. http://dx.doi.org/10.1093/neuonc/noaa215.330.
Gardner, Sharon, Carl Koschmann, Rohinton Tarapore, Jeffrey Allen, Wafik Zaky, Yazmin Odia, Matthew Hall, et al. "CTNI-36. SAFETY OF ONC201 ADMINISTERED TWO CONSECUTIVE DAYS PER WEEK IN PEDIATRIC H3 K27M-MUTANT GLIOMA PATIENTS." Neuro-Oncology 23, Supplement_6 (November 2, 2021): vi67. http://dx.doi.org/10.1093/neuonc/noab196.261.
Damodharan, Sudarshawn, Montserrat Lara-Velazquez, Brooke Carmen Williamsen, Jeffrey Helgager, and Mahua Dey. "Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials." Journal of Personalized Medicine 12, no. 5 (May 20, 2022): 840. http://dx.doi.org/10.3390/jpm12050840.
Grebstad Tune, Benedicte, Heena Sareen, Branka Powter, Smadar Kahana-Edwin, Adam Cooper, Eng-Siew Koh, Cheok S. Lee, et al. "From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients." Biomedicines 11, no. 11 (October 27, 2023): 2907. http://dx.doi.org/10.3390/biomedicines11112907.